Skip to content

Frazier Life Sciences Management, L.P.

Follow

13F filer, CIK 1892134, PALO ALTO, CA

Frazier Life Sciences Management, L.P. reported $4,030,605,205 across 44 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 70.81% of the portfolio.

Accepted , ingested 13F-HR 0001892134-26-000007

Period
2026-09-30
Reported value
$4.03B
Holdings
44
Top 10 weight
70.81%
New
7
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ATTOnew+7,046,271$121M
BRVEnew+5,267,321$106M
ERASadded+4,500,000$66M
ASNDnew+225,155$51.3M
MNKDadded+9,155,491$35.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
BBIOexited-1,548,139-$115M
CYTKexited-1,159,879-$98.8M
ASNDexited-225,155-$60.1M
SVRAreduced-8,607,100-$44.4M
ALKSexited-700,647-$36.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001892134-26-000007, largest first. % of portfolio is the value over $4,030,605,205, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
MIRMMIRUM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,570,392 shares; 2025Q1: 6,795,121 shares; 2025Q2: 6,795,121 shares; 2025Q3: 6,795,121 shares; 2025Q4: 6,795,121 shares; 2026Q1: 7,679,684 shares; 2026Q2: 7,679,684 shares; 2026Q3: 7,679,684 shares 7,679,684$656M16.29%0Timeline
NAMSNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 15,916,418 shares; 2025Q1: 16,116,418 shares; 2025Q2: 16,607,074 shares; 2025Q3: 16,701,956 shares; 2025Q4: 16,943,774 shares; 2026Q1: 16,943,774 shares; 2026Q2: 18,088,902 shares; 2026Q3: 18,988,902 shares 18,988,902$462M11.46%+900,000Timeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 19,391,687 shares; 2025Q1: 22,575,851 shares; 2025Q2: 22,729,436 shares; 2025Q3: 22,729,436 shares; 2025Q4: 22,729,436 shares; 2026Q1: 24,675,188 shares; 2026Q2: 24,975,188 shares; 2026Q3: 29,475,188 shares 29,475,188$432M10.72%+4,500,000Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,985,347 shares; 2025Q1: 5,985,347 shares; 2025Q2: 5,985,347 shares; 2025Q3: 6,652,013 shares; 2025Q4: 6,652,013 shares; 2026Q1: 6,652,013 shares; 2026Q2: 6,652,013 shares; 2026Q3: 6,652,013 shares 6,652,013$390M9.67%0Timeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,785,284 shares; 2025Q1: 8,785,284 shares; 2025Q2: 9,874,511 shares; 2025Q3: 9,874,511 shares; 2025Q4: 9,874,511 shares; 2026Q1: 9,874,511 shares; 2026Q2: 9,874,511 shares; 2026Q3: 9,874,511 shares 9,874,511$261M6.48%0Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 4,129,001 shares; 2025Q2: 4,567,275 shares; 2025Q3: 4,567,274 shares; 2025Q4: 4,567,274 shares; 2026Q1: 4,567,274 shares; 2026Q2: 5,032,915 shares; 2026Q3: 5,282,915 shares 5,282,915$144M3.56%+250,000Timeline
TRVITREVI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,664,774 shares; 2025Q1: 10,259,409 shares; 2025Q2: 10,259,409 shares; 2025Q3: 10,259,409 shares; 2025Q4: 10,259,409 shares; 2026Q1: 9,939,547 shares; 2026Q2: 9,939,447 shares; 2026Q3: 9,539,147 shares 9,539,147$137M3.39%-400,300Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 788,460 shares; 2025Q1: 688,460 shares; 2025Q2: 688,460 shares; 2025Q3: 688,460 shares; 2025Q4: 488,460 shares; 2026Q1: 481,307 shares; 2026Q2: 481,307 shares; 2026Q3: 391,319 shares 391,319$130M3.23%-89,988Timeline
PVLAPALVELLA THERAPEUTICS INC NEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 653,892 shares; 2025Q1: 690,012 shares; 2025Q2: 722,400 shares; 2025Q3: 722,400 shares; 2025Q4: 722,400 shares; 2026Q1: 882,400 shares; 2026Q2: 882,400 shares; 2026Q3: 882,400 shares 882,400$122M3.02%0Timeline
ATTOATTOVIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 7,046,271 shares 7,046,271$121M3%newTimeline
BRVEBRAVEHEART BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 5,267,321 shares 5,267,321$106M2.64%newTimeline
PHATPHATHOM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 10,109,279 shares; 2025Q1: 10,109,279 shares; 2025Q2: 12,466,489 shares; 2025Q3: 12,466,489 shares; 2025Q4: 12,466,489 shares; 2026Q1: 12,466,489 shares; 2026Q2: 12,466,489 shares; 2026Q3: 12,466,489 shares 12,466,489$91M2.26%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,920,805 shares; 2026Q3: 2,330,750 shares 2,330,750$75.3M1.87%+409,945Timeline
DYNDYNE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 1,443,341 shares; 2025Q2: 1,505,984 shares; 2025Q3: 2,718,105 shares; 2025Q4: 3,153,082 shares; 2026Q1: 3,153,082 shares; 2026Q2: 3,153,082 shares; 2026Q3: 3,853,082 shares 3,853,082$62.1M1.54%+700,000Timeline
ACHVACHIEVE LIFE SCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 7,614,836 shares; 2026Q3: 7,614,836 shares 7,614,836$61.6M1.53%0Timeline
MNKDMANNKIND CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 4,225,000 shares; 2026Q1: 5,900,000 shares; 2026Q2: 6,600,000 shares; 2026Q3: 15,755,491 shares 15,755,491$61.4M1.52%+9,155,491Timeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,754,834 shares; 2025Q1: 1,754,834 shares; 2025Q2: 1,654,834 shares; 2025Q3: 1,438,534 shares; 2025Q4: 1,260,000 shares; 2026Q1: 1,354,852 shares; 2026Q2: 1,354,852 shares; 2026Q3: 934,852 shares 934,852$61.2M1.52%-420,000Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,587,527 shares; 2025Q1: 1,397,527 shares; 2025Q2: 1,397,527 shares; 2025Q3: 1,167,527 shares; 2025Q4: 728,644 shares; 2026Q1: 728,644 shares; 2026Q2: 728,644 shares; 2026Q3: 720,338 shares 720,338$56.6M1.4%-8,306Timeline
VORVOR BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 2,543,939 shares; 2026Q1: 2,543,939 shares; 2026Q2: 2,543,939 shares; 2026Q3: 2,743,939 shares 2,743,939$52.4M1.3%+200,000Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 225,155 shares 225,155$51.3M1.27%newTimeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 350,000 shares; 2025Q2: 1,308,138 shares; 2025Q3: 1,627,320 shares; 2025Q4: 1,902,320 shares; 2026Q1: 1,902,320 shares; 2026Q2: 1,902,320 shares; 2026Q3: 1,902,320 shares 1,902,320$50.1M1.24%0Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,925,374 shares; 2026Q2: 4,925,374 shares; 2026Q3: 8,729,516 shares 8,729,516$45.9M1.14%+3,804,142Timeline
AURAAURA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,100,000 shares; 2025Q3: 5,100,000 shares; 2025Q4: 5,100,000 shares; 2026Q1: 5,100,000 shares; 2026Q2: 7,100,000 shares; 2026Q3: 7,100,000 shares 7,100,000$44.6M1.11%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,867,750 shares; 2025Q1: 3,868,750 shares; 2025Q2: 3,868,750 shares; 2025Q3: 3,868,750 shares; 2025Q4: 3,868,750 shares; 2026Q1: 3,796,668 shares; 2026Q2: 22,446,668 shares; 2026Q3: 22,446,668 shares 22,446,668$35.9M0.89%0Timeline
BCRXBIOCRYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 4,009,240 shares; 2026Q2: 4,009,240 shares; 2026Q3: 4,009,240 shares 4,009,240$33.4M0.83%0Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 900,080 shares 900,080$29.2M0.72%newTimeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 470,338 shares; 2025Q1: 470,338 shares; 2025Q2: not reported; 2025Q3: 613,837 shares; 2025Q4: 1,297,198 shares; 2026Q1: 1,438,198 shares; 2026Q2: 1,438,198 shares; 2026Q3: 1,438,198 shares 1,438,198$29M0.72%0Timeline
STTKSHATTUCK LABS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 3,750,000 shares; 2026Q3: 3,750,000 shares 3,750,000$25.6M0.63%0Timeline
IMCRIMMUNOCORE HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 108,762 shares; 2025Q1: 301,170 shares; 2025Q2: 384,782 shares; 2025Q3: 384,782 shares; 2025Q4: 384,782 shares; 2026Q1: 484,782 shares; 2026Q2: 484,782 shares; 2026Q3: 829,752 shares 829,752$25.1M0.62%+344,970Timeline
DSGNDESIGN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,953,547 shares; 2025Q1: 1,953,547 shares; 2025Q2: 1,953,547 shares; 2025Q3: 1,953,547 shares; 2025Q4: 521,000 shares; 2026Q1: not reported; 2026Q2: 1,809,854 shares; 2026Q3: 1,809,854 shares 1,809,854$22.7M0.56%0Timeline
EOLSEVOLUS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 2,435,550 shares; 2025Q3: 2,630,665 shares; 2025Q4: 2,630,665 shares; 2026Q1: 2,630,665 shares; 2026Q2: 2,630,665 shares; 2026Q3: 2,630,665 shares 2,630,665$21M0.52%0Timeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,069,959 shares 1,069,959$19.5M0.48%newTimeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,015,693 shares; 2026Q3: 1,015,693 shares 1,015,693$18.3M0.45%0Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 955,515 shares; 2025Q1: 955,515 shares; 2025Q2: 4,424,725 shares; 2025Q3: 4,424,725 shares; 2025Q4: 4,424,725 shares; 2026Q1: 4,424,725 shares; 2026Q2: 4,824,725 shares; 2026Q3: 4,824,725 shares 4,824,725$16.3M0.4%0Timeline
VALNVALNEVA SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 1,458,333 shares; 2025Q3: 2,291,666 shares; 2025Q4: 2,291,666 shares; 2026Q1: 2,291,666 shares; 2026Q2: 2,291,666 shares; 2026Q3: 2,291,666 shares 2,291,666$14.2M0.35%0Timeline
KLRAKAILERA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,100,000 shares; 2026Q3: 1,200,000 shares 1,200,000$13.7M0.34%+100,000Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,000,000 shares; 2026Q2: 1,000,000 shares; 2026Q3: 1,000,000 shares 1,000,000$11.9M0.3%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,888,238 shares; 2025Q1: 1,410,193 shares; 2025Q2: 1,065,334 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 751,672 shares 751,672$10.1M0.25%newTimeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 4,623,324 shares; 2025Q1: 4,623,324 shares; 2025Q2: 4,623,324 shares; 2025Q3: 4,623,324 shares; 2025Q4: 4,623,324 shares; 2026Q1: 4,447,910 shares; 2026Q2: 4,447,910 shares; 2026Q3: 4,447,910 shares 4,447,910$8.63M0.21%0Timeline
NAMSWNEWAMSTERDAM PHARMA COMPANYQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 500,333 shares; 2025Q1: 500,333 shares; 2025Q2: 500,333 shares; 2025Q3: 500,333 shares; 2025Q4: 500,333 shares; 2026Q1: 500,333 shares; 2026Q2: 500,333 shares; 2026Q3: 500,333 shares 500,333$6.33M0.16%0Timeline
SVRASAVARA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,660,379 shares; 2025Q1: 11,462,301 shares; 2025Q2: 11,462,301 shares; 2025Q3: 11,462,301 shares; 2025Q4: 9,862,301 shares; 2026Q1: 9,720,852 shares; 2026Q2: 9,720,852 shares; 2026Q3: 1,113,752 shares 1,113,752$5.75M0.14%-8,607,100Timeline
XLOXILIO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 422,505 shares; 2026Q2: 422,505 shares; 2026Q3: 422,505 shares 422,505$3.82M0.09%0Timeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 300,000 shares 300,000$3.75M0.09%newTimeline
IBIOIBIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,953,467 shares; 2026Q1: 1,953,467 shares; 2026Q2: 1,953,467 shares; 2026Q3: 1,953,467 shares 1,953,467$2.31M0.06%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
BBIOBRIDGEBIO PHARMA INC1,548,139$115Mshares
CYTKCYTOKINETICS INC1,159,879$98.8Mshares
ASNDASCENDIS PHARMA A/S225,155$60.1Mshares
ALKSALKERMES PLC700,647$36.7Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001892134-26-000007 base2026-11-16